X, R., S, N., K, P., F, M., J, O., AL, C., . . . S, P. (2026). Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease. United European gastroenterology journal, 14(3), e70207. https://doi.org/10.1002/ueg2.70207
Chicago Style (17th ed.) CitationX, Roblin, et al. "Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease." United European Gastroenterology Journal 14, no. 3 (2026): e70207. https://doi.org/10.1002/ueg2.70207.
MLA (9th ed.) CitationX, Roblin, et al. "Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease." United European Gastroenterology Journal, vol. 14, no. 3, 2026, p. e70207, https://doi.org/10.1002/ueg2.70207.